Page 29 - Read Online
P. 29
SUMMARY AND FUTURE DIRECTIONS 9. Berberich S, Jensen V, Hvalby Ø, Seeburg PH, Köhr G. The role
of NMDAR subtypes and charge transfer during hippocampal LTP
induction. Neuropharmacology 2007;52:77‑86.
As compared to patients abroad, Chinese patients 10. Waxman EA, Lynch DR. N‑methyl‑D‑aspartate receptor subtypes:
normally have a long course of recovery. There multiple roles in excitotoxicity and neurological disease. Neuroscientist
are several reasons for this, including inadequate 2005;11:37‑49.
laboratory techniques, absence of standard operating 11. Coyle JT. Glutamate and schizophrenia: beyond the dopamine
hypothesis. Cell Mol Neurobiol 2006;26:365‑84.
procedures for such type of treatment, insufficient drug 12. Ruscheweyh R, Wilder‑Smith O, Drdla R, Liu XG, Sandkühler J.
treatment, less experience in second-line treatment, and Long‑term potentiation in spinal nociceptive pathways as a novel
noncompliance of treatment from time to time. This is target for pain therapy. Mol Pain 2011;7:20.
a big challenge routinely faced by the neurologists in 13. Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J.
checkups, diagnosis, or treatment. Paraneoplastic limbic encephalitis: neurological symptoms,
immunological findings and tumour association in 50 patients. Brain
2000;123:1481‑94.
Viral encephalitis and anti-NMDAR encephalitis have 14. Vitaliani R, Mason W, Ances B, Zwerdling T, Jiang Z, Dalmau J.
similar clinical symptoms such as headache, fever, Paraneoplastic encephalitis, psychiatric symptoms, and
mental disorder and seizures, and similar observations hypoventilation in ovarian teratoma. Ann Neurol 2005;58:594‑604.
in MRI or EEG. It has not been aligned whether 15. Dalmau J, Tüzün E, Wu HY, Masjuan J, Rossi JE, Voloschin A,
Baehring JM, Shimazaki H, Koide R, King D, Mason W,
glucocorticoid should be used in the early treatment Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR. Paraneoplastic
of viral encephalitis. With the incidence of autoimmune anti‑N‑methyl‑D‑aspartate receptor encephalitis associated with
encephalopathies rising, we propose that patients with ovarian teratoma. Ann Neurol 2007;61:25‑36.
unconfirmed encephalitis could use glucocorticoid 16. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X,
Lai M, Dessain SK, Rosenfeld MR, Balice‑Gordon R, Lynch DR.
once they have a CSF puncture, and IVIg can also be Anti‑NMDA‑receptor encephalitis: case series and analysis of the
administered. effects of antibodies. Lancet Neurol 2008;7:1091‑8.
17. Zhou SN, Fu XX, Liu YM, Cao LL, Wang B, Li JJ, Li Y, Gao YJ,
Gong XP. Analyse of one case of paraneoplastic limbic encephalitis
B-lymphocyte depletion therapy mediated by anti-CD20 related with ovary teratoma. Chin J Neurol 2009;42:686‑8. (in
monoclonal antibody has been a brilliant breakthrough Chinese)
in the treatment of various antibody-related autoimmune 18. Dalmau J, Lancaster E, Martinez‑Hernandez E, Rosenfeld MR,
diseases, such as anti-NMDAR encephalitis, rheumatoid Balice‑Gordon R. Clinical experience and laboratory investigations
arthritis, etc. It is important to investigate the possibility in patients with anti‑NMDAR encephalitis. Lancet Neurol
2011;10:63‑74.
of applying this therapy to other higher-incidence neural 19. Lai M, Hughes EG, Peng X, Zhou L, Gleichman AJ, Shu H, Matà S,
autoimmune diseases, such as ophthalmoneuromyelitis. Kremens D, Vitaliani R, Geschwind MD, Bataller L, Kalb RG, Davis R,
The vista is optimistic. Graus F, Lynch DR, Balice‑Gordon R, Dalmau J. AMPA receptor
antibodies in limbic encephalitis alter synaptic receptor location.
Ann Neurol 2009;65:424‑34.
REFERENCES 20. Lancaster E, Lai M, Peng X, Hughes E, Constantinescu R, Raizer J,
Friedman D, Skeen MB, Grisold W, Kimura A, Ohta K, Iizuka T,
1. Lipton SA. Paradigm shift in neuroprotection by NMDA receptor Guzman M, Graus F, Moss SJ, Balice‑Gordon R, Dalmau J.
blockade: memantine and beyond. Nat Rev Drug Discov Antibodies to the GABA (B) receptor in limbic encephalitis with
2006;5:160‑70. seizures: case series and characterisation of the antigen. Lancet
2. Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate Neurol 2010;9:67‑76.
receptor ion channels. Pharmacol Rev 1999;51:7‑61. 21. Lai M, Huijbers MG, Lancaster E, Graus F, Bataller L, Balice‑Gordon R,
3. Cull‑Candy SG, Leszkiewicz DN. Role of distinct NMDA receptor Cowell JK, Dalmau J. Investigation of LGI1 as the antigen in limbic
subtypes at central synapses. Sci STKE 2004;2004:re16. encephalitis previously attributed to potassium channels: a case
4. Wolosker H. D‑serine regulation of NMDA receptor activity. Sci STKE series. Lancet Neurol 2010;9:776‑85.
2006;2006:pe41. 22. Prüss H, Dalmau J, Harms L, Höltje M, Ahnert‑Hilger G, Borowski K,
5. McRoberts JA, Coutinho SV, Marvizón JC, Grady EF, Tognetto M, Stoecker W, Wandinger KP. Retrospective analysis of NMDA
Sengupta JN, Ennes HS, Chaban VV, Amadesi S, Creminon C, receptor antibodies in encephalitis of unknown origin. Neurology
Lanthorn T, Geppetti P, Bunnett NW, Mayer EA. Role of peripheral 2010;75:1735‑9.
N‑methyl‑D‑aspartate (NMDA) receptors in visceral nociception in 23. Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL,
rats. Gastroenterology 2001;120:1737‑48. Morgan D, Cunningham R, Zuckerman M, Mutton KJ, Solomon T,
6. Suen PC, Wu K, Xu JL, Lin SY, Levine ES, Black IB. NMDA receptor Ward KN, Lunn MP, Irani SR, Vincent A, Brown DW, Crowcroft
subunits in the postsynaptic density of rat brain: expression and NS; UK Health Protection Agency (HPA) Aetiology of Encephalitis
phosphorylation by endogenous protein kinases. Brain Res Mol Study Group. Causes of encephalitis and differences in their
Brain Res 1998;59:215‑28. clinical presentations in England: a multicentre, population‑based
7. Gladding CM, Raymond LA. Mechanisms underlying NMDA receptor prospective study. Lancet Infect Dis 2010;10:835‑44.
synaptic/extrasynaptic distribution and function. Mol Cell Neurosci 24. Hu XS, Ouyang M, Li H, Li DF, Dou WB, Wu XY, Chen W,
2011;48:308‑20. Xu SQ. Three cases of anti‑NMDA receptor encephalitis. Chin J
8. Harris AZ, Pettit DL. Recruiting extrasynaptic NMDA receptors Neuroimmunol Neurol 2014;21:66‑8. (in Chinese)
augments synaptic signaling. J Neurophysiol 2008;99:524‑33. 25. Chen L, Zhu FQ, Zhu JH, Li XL. Anti‑NMDA receptor encephalitis:
22 Neuroimmunol Neuroinflammation | Volume 1 | Issue 1 | June 2014